, Tracking Stock Market Picks
Enter Symbol:
Abbott Laboratories (ABT) [hlAlert]

up 12.55 %

Abbott Laboratories (ABT) rated Overweight with price target $52 by Barclays

Posted on: Wednesday,  Oct 7, 2015  1:25 PM ET by Barclays

Barclays rated Overweight Abbott Laboratories (NYSE: ABT) on 10/07/2015, when the stock price was $40.55. Since
then, Abbott Laboratories has gained 12.55% as of 10/07/2015's recent price of $45.64.
If you would have followed this Barclays's recommendation on ABT, you would have gained 12.55% of your investment in 0 days.

Abbott Laboratories is a global, broad-based health care company devoted to discovering new medicines, new technologies and new ways to manage health. Abbott products span the continuum of care, from nutritional products and laboratory diagnostics through medical devices and pharmaceutical therapies. Abbott comprehensive line of products encircles life itself addressing important health needs from infancy to the golden years.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
10/7/2015 1:25 PM Buy
40.55 52.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy